World's Best Scientists 2026 revealed!
Maurizio Recanatini

Maurizio Recanatini

D-Index & Metrics

Chemistry

D-Index
56
Citations
10694
World Ranking
11663
National Ranking
376

Maurizio Recanatini publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Maurizio Recanatini sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 195 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Maurizio Recanatini D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Maurizio Recanatini sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 56 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Maurizio Recanatini is affiliated with the University of Bologna in Italy. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, they have concentrated on subfields including Molecular Biology, Computational Theory and Mathematics, Pharmacology, Infectious Diseases, and Experimental and Cognitive Psychology.

The scientist's work concentrates on topics such as Computational Drug Discovery Methods, Bioinformatics and Genomic Networks, Mental Health Research Topics, Schizophrenia research and treatment, Treatment of Major Depression, Microbial Applications in Construction Materials, and Enzyme Structure and Function.

Frequent co-authors collaborating with Maurizio Recanatini include Luca Menestrina, Matteo Masetti, Andrea Cavalli, Chiara Cabrelle, and Federico Falchi.

Publication venues where Recanatini has appeared multiple times include:

  • Journal of Chemical Information and Modeling
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Medicinal Chemistry
  • QRB Discovery
  • Drug Safety

Notable recent papers authored or co-authored by Recanatini include:

  • Drug Research Meets Network Science: Where Are We?, 2020, Journal of Medicinal Chemistry
  • Targeting the Protein Tunnels of the Urease Accessory Complex: A Theoretical Investigation, 2020, Molecules
  • Computational drug discovery under RNA times, 2022, QRB Discovery
  • Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5, 2023, Journal of Medicinal Chemistry
  • Conduction and Gating Properties of the TRAAK Channel from Molecular Dynamics Simulations with Different Force Fields, 2020, Journal of Chemical Information and Modeling

Best Publications

  • Multi-Target-Directed Ligands To Combat Neurodegenerative Diseases

    Andrea Cavalli;Maria Laura Bolognesi;Anna Minarini;Michela Rosini

  • Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.

    Andrea Cavalli;Elisabetta Poluzzi;Fabrizio De Ponti;Maurizio Recanatini

  • 3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation: A Dual Function Lead for Alzheimer's Disease Therapy§

    Lorna Piazzi;Angela Rampa;Alessandra Bisi;Silvia Gobbi

  • Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.

    Maria Laura Bolognesi;Andrea Cavalli;Luca Valgimigli;Manuela Bartolini

  • Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.

    Lorna Piazzi;Andrea Cavalli;Francesco Colizzi;Federica Belluti

  • A small molecule targeting the multifactorial nature of Alzheimer's disease.

    Andrea Cavalli;Maria Laura Bolognesi;Simona Capsoni;Vincenza Andrisano

  • SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues

    Maurizio Recanatini;Andrea Cavalli;Federica Belluti;Lorna Piazzi

  • Single-molecule pulling simulations can discern active from inactive enzyme inhibitors.

    Francesco Colizzi;Remo Perozzo;Leonardo Scapozza;Maurizio Recanatini

  • Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.

    Marcella Manerba;Marina Vettraino;Luigi Fiume;Giuseppina Di Stefano

  • Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease

    Maria Laura Bolognesi;Rita Banzi;Manuela Bartolini;Andrea Cavalli

  • Dynamic Docking: A Paradigm Shift in Computational Drug Discovery

    Dario Gioia;Martina Bertazzo;Martina Bertazzo;Maurizio Recanatini;Matteo Masetti

  • Phytoestrogens in Postmenopause: The State of the Art from a Chemical, Pharmacological and Regulatory Perspective

    Elisabetta Poluzzi;Carlo Piccinni;Emanuel Raschi;Angela Rampa

  • Determination of lipophilicity by means of reversed-phase thin-layer chromatography: I. Basic aspects and relationship between slope and intercept of TLC equations

    G.L. Biagi;A.M. Barbaro;A. Sapone;M. Recanatini

  • Protein conformational transitions: the closure mechanism of a kinase explored by atomistic simulations.

    Anna Berteotti;Andrea Cavalli;Davide Branduardi;Francesco Luigi Gervasio

  • Target-related applications of first principles quantum chemical methods in drug design.

    Andrea Cavalli;Paolo Carloni;Maurizio Recanatini

  • The role of fragment-based and computational methods in polypharmacology.

    Giovanni Bottegoni;Angelo D. Favia;Maurizio Recanatini;Andrea Cavalli;Andrea Cavalli

  • The role of the peripheral anionic site and cation-pi interactions in the ligand penetration of the human AChE gorge.

    Davide Branduardi;Francesco Luigi Gervasio;Andrea Cavalli;Maurizio Recanatini

  • Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives.

    Angela Rampa;Alessandra Bisi;Federica Belluti;Silvia Gobbi

  • Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238.

    Stefano Rizzo;Manuela Bartolini;Luisa Ceccarini;Lorna Piazzi

  • Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes.

    Angelo Danilo Favia;Andrea Cavalli;Matteo Masetti;Angelo Carotti

  • Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.

    Federica Belluti;Angela Rampa;Lorna Piazzi;Alessandra Bisi

Frequent Co-Authors

Andrea Cavalli
Andrea Cavalli Italian Institute of Technology
Vincenza Andrisano
Vincenza Andrisano University of Bologna
Manuela Bartolini
Manuela Bartolini University of Bologna
Maria Laura Bolognesi
Maria Laura Bolognesi University of Bologna
Francesco Luigi Gervasio
Francesco Luigi Gervasio University College London
Pier Andrea Borea
Pier Andrea Borea University of Ferrara
Paolo Carloni
Paolo Carloni Forschungszentrum Jülich
Vanni Cavrini
Vanni Cavrini University of Bologna
Leonardo Scapozza
Leonardo Scapozza University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying chemistry in the USA opens doors to a variety of related online degrees and career pathways that can complement or expand your expertise. For those interested in law and legal support roles, exploring a criminal justice associate degree online offers foundational knowledge beneficial for regulatory and compliance positions within chemical industries.

Similarly, pursuing a paralegal degree can be a strategic choice for chemistry graduates keen on legal documentation and intellectual property rights related to chemical patents.

For chemistry professionals interested in the commercial side of the pharmaceutical industry, learning how to get into pharmaceutical sales provides a pathway to roles that blend scientific knowledge with business acumen.

Additionally, becoming a pharmacist is a natural extension for many chemistry students. Resources on pharmacist salary and career requirements can help you evaluate this rewarding healthcare direction.

Each of these pathways highlights the versatility of a chemistry background and supports diverse career opportunities through specialized online degrees and professional development routes.

Best Scientists Citing Maurizio Recanatini

Trending Scientists

Recently Published Articles